tiprankstipranks
InMed Pharmaceuticals (INM)
NASDAQ:INM
US Market
INM
InMed Pharmaceuticals
RESEARCH TOOLSreports
Want to see INM full AI Analyst Report?

InMed Pharmaceuticals (INM) Financial Statements

394 Followers

InMed Pharmaceuticals Financial Overview

InMed Pharmaceuticals's market cap is currently $4.97M. The company's EPS TTM is $-1142.54; its P/E ratio is >-0.01; InMed Pharmaceuticals is scheduled to report earnings on May 6, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 25Jun 24Jun 23Jun 22Jun 21
Income Statement
Total Revenue$ 4.94M$ 4.60M$ 4.14M$ 1.09M$ 0.00
Gross Profit$ 1.71M$ 1.10M$ 1.40M$ 543.55K$ 0.00
Operating Income$ -7.92M$ -8.13M$ -8.38M$ -13.79M$ -12.17M
EBITDA$ -7.26M$ -7.06M$ -7.34M$ -18.09M$ -12.17M
Net Income$ -8.16M$ -7.68M$ -7.95M$ -18.60M$ -12.65M
Balance Sheet
Cash & Short-Term Investments$ 15.09M$ 8.99M$ 11.81M$ 8.01M$ 9.16M
Total Assets$ 21.23M$ 16.17M$ 18.69M$ 16.46M$ 12.10M
Total Debt$ 1.01M$ 1.32M$ 518.92K$ 1.02M$ 333.64K
Net Debt$ -14.08M$ -7.67M$ -11.29M$ -6.93M$ -8.77M
Total Liabilities$ 2.92M$ 3.58M$ 2.67M$ 4.78M$ 2.97M
Stockholders' Equity$ 18.30M$ 12.59M$ 16.02M$ 11.69M$ 9.12M
Cash Flow
Free Cash Flow$ -7.77M$ -7.00M$ -7.45M$ -15.62M$ -9.79M
Operating Cash Flow$ -7.77M$ -6.99M$ -7.28M$ -15.58M$ -9.79M
Investing Cash Flow$ 0.00$ -9.29K$ -661.80K$ -673.00K$ -1.73K
Financing Cash Flow$ 12.27M$ 4.65M$ 10.68M$ 15.07M$ 10.85M
Currency in USD

InMed Pharmaceuticals Earnings and Revenue History

Income Statement >

InMed Pharmaceuticals Debt to Assets

Balance Sheet >

InMed Pharmaceuticals Cash Flow

Cash Flow >

InMed Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >